نام: مهرداد
نام خانوادگی: فرخی
آدرس ایمیل:dr.mehrdad.farrokhi@gmail.com
شغل: پزشک
مقالات ISI:
1. Farrokhi M, Etemadifar M, Jafary Alavi MS, Zarkesh-Esfahani SH, Behjati M, Rezaei A, Amani-Beni A. TNF-alpha production by peripheral blood monocytes in multiple sclerosis patients and healthy controls. Immunological investigations. 2015 Aug 18;44(6):590-601.
2. Farrokhi M, Rezaei A, Amani-Beni A, Etemadifar M, Kouchaki E, Zahedi A. Increased serum level of IL-37 in patients with multiple sclerosis and neuromyelitis optica. Acta Neurologica Belgica. 2015 Dec 1; 115(4):609-14.
3. Farrokhi M, Beni AA, Etemadifar M, Rezaei A, Rivard L, Zadeh AR, Sedaghat N, Ghadimi M. Effect of fingolimod on platelet count among multiple sclerosis patients. International journal of preventive medicine. 2015; 6.
4. Farrokhi M, Dabirzadeh M, Fadaee E, Beni AA, Saadatpour Z, Rezaei A, Heidari Z. Polymorphism in leptin and leptin receptor genes may modify leptin levels and represent risk factors for multiple sclerosis. Immunological investigations. 2016 May 18; 45(4):328-35.
5. Farrokhi M, Dabirzadeh M, Dastravan N, Etemadifar M, Ghadimi K, Saadatpour Z, Rezaei A. Mannose-binding Lectin Mediated Complement Pathway in Autoimmune Neurological Disorders. Iranian Journal of Allergy, Asthma and Immunology. 2016 Jun 1; 15(3):251.
6. Farrokhi M, Moeini P, Fazilati M, Nazem H, Faraji S, Saadatpour Z, Fadaei E, Saadatpour L, Rezaei A, Ansaripour S, Amani-Beni A. Polymorphisms in CD14 Gene May Modify Soluble CD14 Levels and Represent Risk Factors for Multiple Sclerosis. Immunological investigations. 2016 Nov 2:1-8.
7. Farrokhi M, Saadatpour Z, Fadaee E, Saadatpour L, Rezaei A, Moeini P, Beni AA. A Novel Approach to Discriminate Subgroups in Multiple Sclerosis. Iranian Journal of Allergy, Asthma and Immunology. 2017 Dec 30; 15(6):536-46.
8. Farrokhi M, Masoudifar A, Derakhshan A, Saadatmand S, Rouhi-Boroujeni H, Etemadifar M, Rezaei-Zarji S, Javid A, Nobakht R, Deyhimi M, Ekramnia A. The Association of Interleukin-16 Gene Polymorphisms with IL-16 Serum Levels and Risk of Multiple Sclerosis. Immunological Investigations. 2017 Feb 3:1-9.
9. Farrokhi M, Jahanbani-Ardakani H, Eskandari N, Shaygannejad V, Ghafari S. Cerebrospinal Fluid and Serum Markers of Inflammation in Patients with Multiple Sclerosis. Advances in Neuroimmune Biology. 2017 Jan 1; 6(3-4):149-52.
10. Farrokhi M. Sema3A and multiple sclerosis. Gene. 2017 Jun 5; 615:41.
11. Farrokhi M, Peykanpour F. Statistical Comments on “Salivary Iron (Fe) Ion Levels, Serum Markers of Anemia and Caries Activity in Pregnant Women”. Revista Brasileira de Ginecologia e Obstetricia. 2017.
12. Farrokhi M, Amani-Beni A. Statistical Comments on” Assessment of Musculoskeletal Strength and Levels of Fatigue During Different Phases of Menstrual Cycle in Young Adults”. Journal of clinical and diagnostic research: JCDR. 2017 Jul; 11(7):CL01.
13. Farrokhi M, Masoudifar A, Peykanpour F. Interleukin 17 and 10 in relapsing remitting multiple sclerosis. Journal of the Neurological Sciences. 2017 Jul 15; 378:63.
14. Farrokhi M, Arjaki D. Statistical Comments on “Cytokine and Chemokine Profiles in Patients with Neuromyelitis Optica Spectrum Disorder”. Neuroimmunomodulation. 2017; 24(2):120-.
15. Farrokhi M, Peykanpour F. Vascular Endothelial Growth Factor–loaded Bioresorbable Delivery System for Pulp Regeneration. Journal of Endodontics. 2017 Sep 1; 43(9):1414.
16. Farrokhi M. Reply to: Statistical support for Sema3A and multiple sclerosis. Gene. 2017 Oct 5; 631:52.
17. Farrokhi M, Shirian N. Statistical comments on “no seasonal variation in physical activity of Han Chinese living in Beijing”. Int J Behav Nutr Phys Act. 2017 Nov 3; 14(1):151.
18. Farrokhi M. Statistical comments on “Does player time-in-game affect tackle technique in elite level rugby union?”. J Sci Med Sport. 2018 Sep; 21(9):872.
19. Farrokhi M. Assessment of bioelectrical activity of pelvic floor muscles. Eur J Phys Rehabil Med. 2018 Aug; 54(4):645.
20. Farrokhi M. Seasonal variation of vitamin D and Epstein-Barr virus antibody in multiple sclerosis patients. Eur J Neurol. 2018 Sep; 25(9):e103.
21. Etemadifar M, Najafi MA, Najafi MR, Alavi A, Nasr Z, Farokhi M, Rezaei A. Multiple sclerosis and hyperprolactinemia: a case-control study. Acta Neurol Belg. 2015 Sep; 115(3):253-7.
22. Farrokhi, M., Ebrahimi, M. & Peykanpour, F. Effect of surgical intraocular pressure lowering on retinal structures—nerve fibre layer, foveal avascular zone, peripapillary and macular vessel density: 1 year results. Eye (2019). https://doi.org/10.1038/s41433-019-0674-x
سایر مقالات:
1. Fereshteh Alsahebfosoul, Rasoul Salehi, Masoud Etemadifar, Ahmad Zavaran Hosseini, Mohammad Kazemi, Mehrdad Farokhi, and Mohadaseh Behjati, Association between CD127 Gene Polymorphism and Susceptibility to Multiple Sclerosis, SOJ Immunology,2016.
2. Mehrdad Farrokhi, Masoud Etemadifar, Ali Rezaei, Ali Amani Beni, Multiple sclerosis among patients with previous diagnosis of leishmaniasis, American journal of experimental and clinical research, 2, 2, 2015.
3. Aryan Rafiee Zadeh, Mehrdad Farrokhi, Masoud Etemadifar, Ali Amani Beni, Nastaran Dastravan, Prevalence of benign tumors among patients with multiple sclerosis, American journal of experimental and clinical research, 2, 4, 2015.
کنفرانس های بین المللی:
1. Speech: 22th Congress of Neurology and Clinical Electrophysiology of Iran.
2. Speech: The 3rd International Congress of Immunology, Asthma and Allergy.
3. Poster1: Third Neuroscience Congress.
4. Poster2: Third Neuroscience Congress.
5. Poster: The First MENACTRIMS.
6. Poster1: 12th Multiple Sclerosis Congress.
7. Poster2: 12th Multiple Sclerosis Congress.
8. Poster: 23th Congress of Neurology and Clinical Electrophysiology of Iran.
9. Poster: International Congress of Endocrine and Metabolism Updates.
اختراعات:
1-دستگاه بخیه کش
2-
کتاب ها:
بیماری مولتیپل اسلکروزیس
